prof. dr. W. (Wim) Timens



  1. A cellular census of human lungs identifies novel cell states in health and in asthma

    Vieira Braga, F. A., Kar, G., Berg, M., Carpaij, O. A., Polanski, K., Simon, L. M., Brouwer, S., Gomes, T., Hesse, L., Jiang, J., Fasouli, E. S., Efremova, M., Vento-Tormo, R., Talavera-López, C., Jonker, M. R., Affleck, K., Palit, S., Strzelecka, P. M., Firth, H. V., Mahbubani, K. T., Cvejic, A., Meyer, K. B., Saeb-Parsy, K., Luinge, M., Brandsma, C-A., Timens, W., Angelidis, I., Strunz, M., Koppelman, G. H., van Oosterhout, A. J., Schiller, H. B., Theis, F. J., van den Berge, M., Nawijn, M. C. & Teichmann, S. A., 17-Jun-2019, In : Nature Medicine.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Differential lung tissue gene expression in males and females: implications for the susceptibility to develop COPD

    van den Berge, M., Brandsma, C-A., Faiz, A., de Vries, M., Rathnayake, S. N. H., Paré, P. D., Sin, D. D., Bossé, Y., Laviolette, M., Nickle, D. C., Hao, K., Obeidat, M., Dragani, T. A., Colombo, F., Timens, W. & Postma, D. S., 4-Jun-2019, In : European Respiratory Journal. 53, 6, 14 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  3. A Bronchial Airway Gene Expression Signature of Future Lung Function Decline Is Enriched in XBP1-Regulated Genes

    Becker, E. J., Faiz, A., Van den Berge, M., Timens, W., Hiemstra, P. S., Liu, G., Zhang, X., Alekseyev, Y. O., O'Connor, G. T., Lam, S., Spira, A., Lenburg, M. E. & Steiling, K., 2019, In : American Journal of Respiratory and Critical Care Medicine. 199, 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

View all (445) »

Press / Media
  1. Kankercellen onder de loep

    Wim Timens & Bert Vegt, van der


    1 item of media coverage

    Press/Media: Public Engagement ActivitiesPopular

  2. Zien welke kanker het is

    Bert Vegt, van der & Wim Timens


    1 item of media coverage

    Press/Media: Public Engagement ActivitiesPopular

  3. PD-L1 kleuring vereist bij eerstelijnsbehandeling urotheelcarcinoom met pembrolizumab

    Wim Timens


    1 item of media coverage

    Press/Media: Expert CommentProfessional

View all (5) »

  1. Weefselonderzoek bij kanker

    Bert Vegt, van der (Speaker), Wim Timens (Speaker)

    Activity: Talk or presentationPopular

  2. Scientific Advisory Board

    Wim Timens (Consultant)

    Activity: ConsultancyProfessional


    Wim Timens (Consultant)

    Activity: ConsultancyProfessional

View all (49) »

View graph of relations

ID: 152285